William C. Gerth

Statistics

Publications

Citations

1.7K

H-Index

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Brigham and Women's Hospital

University of Michigan

United States Military Academy

University of Florida

William C. Gerth is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacoeconomics, pharmacy, and cost-effectiveness analysis.

Publications per year

1995–2014

Publications

Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?

Hans‐Georg Eichler, Sheldon X. Kong, William C. Gerth et al. · Value in Health · 2004 · 803 citations · Full text

Pharmacy, Economics, Pharmacoeconomics +15

Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes

Paul R. Conlin, William C. Gerth, James M. Fox et al. · Clinical Therapeutics · 2001 · 184 citations

Medicine, Pharmacology, Pharmacotherapy +11

Antihypertensive persistence and drug class.

Michael Marentette, William C. Gerth, David K. Billings et al. · PubMed · 2002 · 127 citations

Medicine, Pharmacology, Pharmacotherapy +14

The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss

William C. Gerth, George W. Carides, Erik J. Dasbach et al. · PharmacoEconomics · 2001 · 101 citations

Public Health, Health Policy, Neurology +17

Costs and effects of enalapril therapy in patients with symptomatic heart failure: An economic analysis of the studies of left ventricular dysfunction (SOLVD) treatment trial

Henry A. Glick, J.R. Cook, Bruce Kinosian et al. · Journal of Cardiac Failure · 1995 · 95 citations

Pharmacy, Cardiology, Pharmacoeconomics +8

1–5 of 18